| Literature DB >> 31533908 |
Roy W Beck1, Richard M Bergenstal2, Lori M Laffel3, John C Pickup4.
Abstract
Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of insulin delivery. In the next 5 years, as many advances are expected in technology for the management of diabetes as there have been in the past 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery. Expansion of the use of technology will be needed beyond endocrinology practices to primary-care settings and broader populations of patients. Tools to support decision making will also need to be developed to help patients and health-care providers to use the output of these devices to optimise diabetes management.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31533908 DOI: 10.1016/S0140-6736(19)31142-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321